Big Pharma's Biggest Losers

In the following video, Fool contributor Maxxwell Chatsko recaps the latest earnings results from the pharmaceutical industry for investors. Some Big Pharma companies have traversed the patent cliff in relatively good shape with new therapies waiting in the wings to fill the void in sales. Others, such as AstraZeneca and Eli Lilly , are just beginning their slide, but their immediate and long-term futures are more difficult to pin down.

While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.

The article Big Pharma's Biggest Losers originally appeared on Fool.com.

Max Macaluso, Ph.D. has no position in any stocks mentioned. Fool contributor Maxx Chatsko has no position in any stocks mentioned. Check out his personal portfolio, his CAPS page, or follow him on Twitter @BlacknGoldFool to keep up with his writing on energy, bioprocessing, and emerging technologies.The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.